4//SEC Filing
Ballantyne Charles Evan 4
Accession 0001209191-23-024125
CIK 0001819411other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 5:36 PM ET
Size
8.1 KB
Accession
0001209191-23-024125
Insider Transaction Report
Form 4
Ballantyne Charles Evan
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-04-10+100,000→ 100,000 totalExercise: $4.79Exp: 2033-04-10→ Common Stock (100,000 underlying) - Award
Restricted Stock Units
2023-04-10+50,000→ 50,000 total→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]The shares underlying the option shall vest 25% on April 10, 2024 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F3]The RSUs vest upon the board of directors' certification of the Issuer's share price reaching $10.00 per share based on the 10-day volume weighted average share price, subject to Reporting Person's continuous service through such vesting date.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001371742
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 5:36 PM ET
- Size
- 8.1 KB